Treatment Watch
2591 eventsUpdated todayFDA drug approvals, PDUFA decisions, orphan designations, and breakthrough therapy designations for rare diseases — sourced daily from FDA.gov.
All eventsFDA approval (873)PDUFA date (0)Orphan designation (0)Breakthrough therapy (0)Complete response letter (0)Upcoming only·Year:All2015201420132012201120102009200820072006
21 events · FDA approval · 2014
Dec 12
2014
Oct 23
2014
FDA approvalOrphan drug
Rare thrombotic disorder due to a coagulation factors defect· Takeda Development Center Americas, Inc.
Oct 15
2014
FDA approvalOrphan drug
Oct 15
2014
Jul 22
2014
FDA approvalOrphan drug
Multiple pterygium-malignant hyperthermia syndrome· Eagle Pharmaceuticals, Inc.
Jul 3
2014
FDA approvalOrphan drug
Primary cutaneous peripheral T-cell lymphoma not otherwise specified· Acrotech Biopharma LLC
Jun 13
2014
FDA approvalOrphan drug
Immunodeficiency with isotype or light chain deficiencies with normal number of B-cells· Cardinal Health 414, LLC
Jun 9
2014
Apr 28
2014
FDA approvalOrphan drug
Acute myeloblastic leukemia with maturation· Nova Laboratories Limited
Mar 28
2014
FDA approvalOrphan drug
Multisystem inflammatory syndrome in children and adults· Bioverativ Therapeutics, Inc.
Mar 11
2014
FDA approval
Feb 24
2014
FDA approvalOrphan drug
AKT2-related familial partial lipodystrophy· Chiesi Farmaceutici S.p.A.
Not medical advice — always consult your healthcare provider before making treatment decisions.
Data sourced from FDA.gov and openFDA, updated daily. Dates are subject to change. Always verify with FDA.gov for official decisions.